OperationBig Itch
The U.S. military named their tick bioweapons program "Operation Big Itch." The declassified record raises a question every functional and naturopathic clinician should ask: what co-pathogens were engineered into the tick population — and are they driving the chronic illness cases we cannot explain today?
When the U.S. military named their arthropod bioweapons initiative "Operation Big Itch" in 1954, they were not being ironic. They genuinely deployed 670,000 tropical rat fleas from cluster bombs over Dugway Proving Ground, Utah, to verify that fleas could survive aerial delivery and latch onto a human host. They could. The Pentagon was delighted. Nobody pushed further.
What followed was a golden era of inspired program names. Operation Big Buzz released 300,000 yellow fever mosquitoes over Georgia in 1955. Operation Drop Kick extended the testing in 1956 — inexplicably named after a football maneuver. Operation Mongoose, the CIA's Cuba destabilization campaign, included C-123 aircraft skimming the Caribbean at night to drop infected ticks on sugarcane workers. The operative's mission debrief included the instruction: "Burn all the clothes you took to Cuba. Burn everything." His infant son developed a 105-degree fever requiring emergency surgery shortly after. The tick mission was eventually canceled because Cuban winds made accurate payload delivery too unreliable. This is not fiction.
All of this sits under Project 112 — authorized by Defense Secretary McNamara in 1962, with 134 scheduled tests and the capacity to produce 100 million infected mosquitoes per month, involving every branch of the armed services. The military denied its existence for four decades, until CBS News forced acknowledgment in 2000. Forty years of denial. One news segment.
Meanwhile, Plum Island Animal Disease Center sat 13 miles from Old Lyme, Connecticut — the town that gave Lyme disease its name. From 1952 to 1969 it was operated by the Army Chemical Corps for biological warfare research. Outdoor experiments with live pathogens were documented. Test animals "mingled with wild deer." Wild birds flew freely on and off the island. The Department of Agriculture later claimed Lyme disease was "never researched" there. Classified documents from 1993 said otherwise.
In 2014, researchers found suppressed research materials in the garage of Willy Burgdorfer — the scientist who identified the Lyme bacterium in 1982, and who spent his earlier career weaponizing tick-borne pathogens for the U.S. government. His materials showed he had identified a second pathogen ("Swiss Agent," Rickettsia helvetica) in Lyme patients' blood in the late 1970s — and been told to leave it out of his published research. Before he died he left a note: "I wondered why somebody didn't do something." When an interviewer's camera stopped rolling, Burgdorfer reportedly smiled: "I didn't tell you everything."
In 2019, the House passed an amendment requiring the Pentagon to investigate whether it weaponized ticks between 1950 and 1975 and whether any escaped — by accident or by design. That investigation is ongoing. The CDC is re-examining 30,000 archived blood samples using modern molecular techniques, specifically looking for the Swiss Agent co-pathogen that Burgdorfer was ordered to suppress nearly fifty years ago.
The suppression of the Swiss Agent finding may be the single most consequential act of scientific censorship
in the history of American infectious disease medicine.
🧬 Naturopathic & Functional Medicine Lens
What the declassified record means for your health. Naturopathic and functional medicine view tick-borne illness as a multi-system, multi-pathogen condition — not a single bug with a single intervention. These are the key takeaways from that lens: what to test, what to treat, what gets missed, and why so many patients are told they are fine when they are not.
Babesia
A malaria-like parasite invading red blood cells. Classic signs are air hunger, drenching night sweats, temperature dysregulation, vivid dreams, and crushing fatigue that don't fit standard Lyme — because they aren't standard Lyme. Because Babesia is a parasite — not a bacterium — it simply does not respond to standard bacterial interventions. Naturopathic and functional medicine practitioners have taken interest in botanical approaches: Johns Hopkins researchers documented meaningful activity against Babesia from artemisinin and garlic-derived diallyl disulfide in laboratory studies.
Bartonella
An intracellular bacterium that hides inside the walls of blood vessels and inside red blood cells, making it notoriously difficult to clear and to diagnose. Neuropsychiatric symptoms dominate: anxiety, rage episodes, intrusive thoughts, burning foot pain, stretch marks, vascular inflammation, profound brain fog. It is increasingly recognized as the primary hidden driver behind "treatment-resistant" chronic Lyme cases. Galaxy Diagnostics' ePCR platform is the current clinical gold standard for detection. From a naturopathic and botanical perspective, NutraMedix Nutra-BRT (nutramedix.com) — a synergistic liquid extract of Huacapurana bark (Campsiandra angustifolia) and Houttuynia (Houttuynia cordata) — has been used extensively in ILADS-aligned herbal protocols and is stocked by Dr. Jill Crista on her own clinical dispensary. Japanese knotweed (Polygonum cuspidatum) and Sida acuta are also documented in the botanical Lyme literature for Bartonella support.
Rickettsia / Swiss Agent
What it is: Rickettsia helvetica — nicknamed "Swiss Agent" by Burgdorfer — is an obligate intracellular bacterium in the spotted fever group, a close cousin to the agent of Rocky Mountain Spotted Fever. It lives exclusively inside your cells, invisible to standard blood cultures and resistant to ordinary antibiotics. Unlike Borrelia, which hides in tissues, Rickettsia actively destroys the cells lining your blood vessels — causing widespread vascular inflammation from the inside out.
The conundrum: Standard Lyme testing doesn't look for it. Standard Rickettsia tests are calibrated for Rocky Mountain Spotted Fever — a different species. Swiss Agent sits in a diagnostic no-man's-land: too similar to catch on Lyme panels, too different to show up on standard Rickettsia screens. Patients with it are frequently told their tests are "negative" and their symptoms are psychosomatic. Meanwhile, untreated Rickettsia vascular inflammation can drive headache, sudden hearing loss, cardiac arrhythmia, meningitis-like syndrome, and in severe cases, multi-organ failure — none of which reads as "tick bite" on a standard intake form years later.
What Burgdorfer found and buried: In the late 1970s, Burgdorfer tested archived blood samples from Lyme patients and found "very strong" antibody reactions to Swiss Agent — suggesting a significant portion of what was being diagnosed as Lyme disease was actually Rickettsia co-infection, or Rickettsia alone. He was told to omit this from his published research. The implication is staggering: thousands of "Lyme" patients treated with doxycycline alone may have had an unaddressed Rickettsia co-infection responding to a different treatment protocol — or the same doxycycline at a different dose and duration than Borrelia requires. The CDC's current re-examination of 30,000 archived samples is specifically searching for this pathogen. If confirmed at scale, it rewrites four decades of Lyme treatment failure.
Treatment distinction: Doxycycline does cover Rickettsia — but the dose and duration required may differ from Borrelia protocols. An ILADS-trained physician should specifically test for Rickettsia species via IgG/IgM serology (request spotted fever group panel, not just RMSF) or specialized PCR. This is not on the standard Lyme co-infection panel and must be specifically requested.
The highest-stakes clinical case for comprehensive co-infection testing comes from published neurology research. Neurologist Dr. Dale Bredesen's 2024 case series in Biomedicines documented a patient who had reversed Alzheimer's-type cognitive decline for five years on his ReCODE Protocol — then experienced re-decline. Evaluation revealed active Babesia, traceable to a tick bite a decade earlier. Her Lyme had been treated at the time of a bullseye rash. Her co-infections had never been tested. Once Babesia was treated, her cognition recovered to the 96th percentile for her age and has remained stable. Bredesen's protocol now includes standard screening for Borrelia, Babesia, Bartonella, Ehrlichia, and Anaplasma as part of every cognitive health evaluation — because he classifies chronic tick-borne infection as a primary "Type 1 Inflammatory" driver of neurodegeneration, as actionable as insulin resistance or hormonal deficiency. (apollohealthco.com)
Naturopathic physician Dr. Jill Crista — ILADS-trained, practicing in Wisconsin's Lyme endemic zone — identified a critical pattern explaining why so many Lyme patients plateau in treatment: a significant subset have unaddressed mold illness actively suppressing immune function. Her Break the Mold framework puts it simply: the immune system cannot fight tick-borne co-infections effectively while being suppressed by mycotoxins. Remove the mold exposure first. This sequence matters. She co-teaches complex chronic illness protocols with Dr. Neil Nathan, and the Lyme-mold connection is now one of the central insights in treatment-resistant cases. (drcrista.com)
A third layer of complexity comes from genetics. Dr. Ben Lynch, ND, author of Dirty Genes, has directly connected MTHFR gene variants to why Lyme patients struggle to recover. The MTHFR enzyme drives the methylation cycle responsible for producing glutathione — the body's master detoxifier. Chronic infection generates enormous inflammatory and toxic burden. If methylation is impaired (affecting roughly 40–50% of the population to varying degrees), the body simply cannot clear those byproducts — keeping the patient chronically ill regardless of what interventions are pursued. Lynch explicitly cites Lyme disease as a primary clinical indication for MTHFR testing, and his StrateGene platform maps the full methylation, folate, histamine, and detox genome into a personalized supplement roadmap. (drbenlynch.com)
Dr. Kara Fitzgerald, ND, IFM faculty and lead researcher on DNA methylation and biological aging, adds an epigenetic dimension: chronic infections like Lyme and Bartonella measurably accelerate biological aging by disrupting methylation patterns across immune genes. Her published gut microbiome research on post-treatment Lyme syndrome identified elevated Blautia species as a measurable signature of ongoing dysfunction — a potential new diagnostic marker for the vast group of patients who are told their treatment is "complete" but who continue to suffer. Her methylation-supportive diet — dark leafy greens, beets, eggs, liver, methyl-B vitamins — supports immune gene repair. Treating the infection without restoring the epigenetic environment, she notes, is like bailing a boat without patching the hull. (drkarafitzgerald.com)
Observations & Takeaways for the Informed Reader
What follows is not medical advice. It is a synthesis of published observations, clinical frameworks, and documented patterns that practitioners working through a naturopathic and functional medicine lens have noted in the peer-reviewed and clinical literature. These observations are offered for educational purposes — they are the questions a well-informed patient might bring to a knowledgeable clinician.
📋 Standard Testing Has Known Blind Spots
Researchers and clinicians working through a functional medicine lens have documented that two-tier CDC Lyme testing misses a significant proportion of cases. Practitioners such as Dr. Jill Crista (drcrista.com) and ILADS-affiliated physicians have observed that a more complete picture often includes testing for Babesia, Bartonella, Ehrlichia, and Rickettsia alongside standard inflammatory biomarkers — not because this is a universal prescription, but because co-infections are consistently found where standard panels returned negative results.
🦠 Each Pathogen Has a Different Herbal Profile
One of the most consistent observations across ILADS-trained and naturopathic practitioners is that Lyme co-infections do not respond to the same botanical interventions. For Bartonella specifically, ILADS-aligned herbal protocols have increasingly centered on NutraMedix Nutra-BRT (Huacapurana + Houttuynia) and for core Borrelia support, Nutra-BRL (Samento + Banderol) — both from nutramedix.com. Dr. Crista, Dr. Mark Hyman (drhyman.com), and ilads.org each emphasize that missing a co-infection means the botanical protocol for the other pathogen simply cannot hold ground.
🌿 Botanical Protocols: The Herbal Lyme Toolkit
NutraMedix (nutramedix.com) has become the botanical reference line in ILADS-aligned herbal Lyme protocols. Nutra-BRT — Huacapurana bark + Houttuynia — is specifically formulated for Bartonella microbial and immune support; Nutra-BRL — Samento (cat's claw, Uncaria tomentosa) + Banderol (Otoba parvifolia) — forms the Borrelia-targeted core. Samento has been documented in peer-reviewed research for its anti-spirochetal properties and immune modulation. These are liquid herbal extracts, not pharmaceuticals — they support the body's terrain, preserve the gut microbiome, and can be layered alongside methylation support and detox protocols. Nutra-BRT is stocked by Dr. Jill Crista (drcrista.com) through her own clinical dispensary.
🧬 The Methylation Connection
Dr. Ben Lynch, ND, author of Dirty Genes (drbenlynch.com), has documented through StrateGene genomic analysis that MTHFR, COMT, and MTRR variants appear at elevated rates in chronically ill Lyme patients. The functional observation: impaired methylation affects detoxification, neurotransmitter clearance, and B12 recycling — which may help explain the neuropsychiatric symptom constellation that appears in many chronic Lyme presentations. Dr. Chris Masterjohn PhD (chrismasterjohnphd.substack.com) provides additional nuance on nutritional biochemistry within this context.
🔥 Inflammation as the Common Language
Dr. Rhonda Patrick PhD (foundmyfitness.com) has extensively documented the mechanisms through which omega-3 fatty acids, vitamin D, and micronutrient status modulate inflammatory signaling. This intersects with what functional medicine practitioners observe in Lyme patients: elevated hsCRP, depleted zinc, vitamin D insufficiency, and elevated homocysteine consistently emerge in workups. Dr. Dale Bredesen MD (apollohealthco.com) has published data showing that homocysteine above 7 µmol/L correlates with measurable annual brain volume loss — a finding with direct relevance to neurological Lyme cases.
🧠 The Brain May Be the Last Thing Evaluated
Bredesen's published case series includes a patient who successfully reversed Alzheimer's-type cognitive decline under the ReCODE Protocol — only to relapse years later. The underlying driver: untreated Babesia that had been present and undetected throughout. Bartonella's neuropsychiatric presentation — documented in the literature as anxiety, intrusive thoughts, and cognitive impairment — is frequently attributed to psychiatric causes rather than infection. These documented patterns suggest the brain is not a separate conversation from tick-borne illness.
🍄 Mold, Metals & the Terrain: Why the Body Can't Heal
Dr. Crista's clinical framework, detailed in Break the Mold, documents a recurring pattern: patients with chronic Lyme who do not improve often have concurrent mold-related illness suppressing immune function. Heavy metal burden — mercury, lead, arsenic — co-occurs frequently and further impairs detoxification. Dr. Kara Fitzgerald (drkarafitzgerald.com) has observed that biotoxin and environmental load measurably affects immune gene expression and methylation status. The naturopathic and functional medicine lens holds that no botanical protocol for infection can succeed while the body's terrain remains overwhelmed by environmental co-stressors. Addressing mold, metals, and gut ecology is not a secondary consideration — it is often the prerequisite.
